SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Mylan Labs
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
384 7 0 MYL
Emcee:  Brett Koplin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
59 Hark, Because 8 companies are coming out with a generic simultaneously no one James Silverman-4/23/1997
58 Insider buying by M. Puskar CB $606,500 for 50,000 shares on 4/3/97. I will trharkenman-4/23/1997
57 Stock up by more than 1 point but no news. Maybe you are right.harkenman-4/23/1997
56 WSJ article on Mylan: Generic Drug Cos.' 1Q -2: Mylan Seen Having Poor Qtrharkenman-4/18/1997
55 Mylan should be reporting earnings soon and I expect for them to report a loss harkenman-4/18/1997
54 This kind of optimism could be a prelude to.... A stock than only has one way Richard F Uzelac-4/18/1997
53 The margins will be very very thin since Myaln will market the product while MTharkenman-4/9/1997
52 James--- Do you have any feel for the type of margins MYL can expect to receiveB. W. Lewis-4/9/1997
51 I own shares of WATS via Bolar and Circa. Also playing another WATS connectioJames Silverman-4/2/1997
50 JS If you are interested in playing the Somerset card, you can do so with eithB. W. Lewis-4/2/1997
49 To all: Let's keep this thread alive as new information arises. There may The Insider-4/2/1997
48 I don't own shares in MYL, but I am aware or have heard nice comments in reJames Silverman-4/1/1997
47 No "new" products, no first approvals, poor focus/strategy for producharkenman-4/1/1997
46 'Twas our (former) good friends at Oppenheimer... NEW YORK -(Dow Jones)-David Lawrence-4/1/1997
45 Thanks. I figure someone just discovered something they don't like regardiThe Insider-4/1/1997
44 Not a thing. The rest of the sector looks normal. We're always the last to David Lawrence-4/1/1997
43 Anyone know anything about today's drop?The Insider-4/1/1997
42 delta 8,9 is not part of their formulation nor its required by the FDA as of cuharkenman-3/3/1997
41 Thanks for the reply I'll take your word for it-. MYL won't say much James Silverman-3/3/1997
40 Answer to question # 1, over a year, Check the FDC Pink Sheets. Answer to quesharkenman-3/2/1997
39 A couple of questions. How long has Mylan been in litigation over tamoxifen? James Silverman-3/1/1997
38 I would dump it if I were you. Look at the 5 year performance of this stock. harkenman-3/1/1997
37 Just another mutual fund that will underperform the market.harkenman-2/28/1997
36 JS WHILE I DON'T SEE ANY FUNDAMENTALS THAT MAKE ME WANT TO GRAB MORE MYL SB. W. Lewis-2/27/1997
35 Does this one look undervalued to you?Duane Sieren-2/15/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News